Agonist action at D(2(long)) dopamine receptors: Ligand binding and functional assays

British Journal of Pharmacology

Volumn 124, Issue 5, 1998, Pages 978-984

  Gardner, B ^a   Strange, P G ^a,b  

^a The University   (United Kingdom)

^b UNIVERSITY OF READING   (United Kingdom)

Author keywords

35S GTP S binding; Agonist action; Dopamine; Ligand binding; Receptors

Indexed keywords

APOMORPHINE; BROMOCRIPTINE; DOPAMINE; DOPAMINE 2 RECEPTOR; GUANOSINE TRIPHOSPHATE; LISURIDE; PERGOLIDE; QUINPIROLE; ROPINIROLE; TALIPEXOLE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); LIGAND; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; CHO CELL; LIGAND BINDING; MODEL; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; DRUG POTENTIATION; HAMSTER; HUMAN; METABOLISM; PHYSIOLOGY;

ANIMALS; CHO CELLS; CRICETINAE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; LIGANDS; RECEPTORS, DOPAMINE D2; RECOMBINANT PROTEINS;

EID: 0031595716     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701926     Document Type: Article

References (35)

1. BIRNBAUMER, L., ABRAMOWITZ, J. & BROWN, A.M. (1990). Receptor-effector coupling by G-proteins. Biochim. Biophys. Acta, 1031, 163-224.
2. CASTRO, S. & STRANGE, P.G. (1993). Differences in the ligand binding properties of the long and short versions of the D2 dopamine receptor. J. Neurochem., 60, 372-375.
3. CHIO, C.L., LAJINESS, M.E. & HUFF, R.M. (1994). Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors. Mol. Pharmacol., 54, 51-60.
4. CIVELLI, O., BUNZOW, J.R. & GRANDY, G.K. (1993). Molecular diversity of the dopamine receptors. Ann. Rev. Pharmacol. Toxicol., 32, 281-307.
5. DE LEAN, A., STADEL, J.M. & LEFKOWITZ, R.J. (1980). A ternary complex model explains the agonist specific binding properties of the adenylyl cyclase coupled β-adrenergic receptor. J. Biol. Chem., 255, 7108-7117.
6. 2-long dopamine receptors expressed in recombinant cells. Br. J. Pharmacol., 118, 1544-1550.
7. (short) dopamine receptors determined in ligand binding and functional assays. J. Neurochem., 69, 2589-2598.
8. HARLEY, E.A., MIDDLEMISS, D.M. & RAGAN, C.I. (1995). Relationship between inhibition of cyclic AMP production in Chinese hamster ovary cells expressing the rat D2(444) receptor and antagonist/agonist binding ratios. Br. J. Pharmacol., 115, 1307-1313.
9. s. J. Biol. Chem., 265, 1388-1393.
10. HAYES, G., BIDEN, T.J., SELBIE, L.A. & SHINE, J. (1992). Structural subtypes of the dopamine D2 receptor are functionally distinct: expression of the cloned D2A and D2B subtypes in a heterologous cell line. Mol. Endocrinol., 6, 920-926.
11. 2-adrenergic receptor transmembrane domain inhibits both receptor dimerisation and activation. J. Biol. Chem., 271, 16384-16392.
12. JAHANGEER, S. & RODBELL, M. (1993). The disaggregation theory of signal transduction revisited; further evidence that G-proteins are multimeric and disaggregate to monomers when activated. Proc. Natl. Acad. Sci. U.S.A., 90, 8782-8786.
13. KENAKIN, T.P. (1993). Pharmacological Analysis of Drug-receptor Interactions. New York: Raven Press.
14. LAHTI, R.A., FIGUR, L.M., PIERCEY, M.F., RUPPEL, P.L. & EVANS, D.L. (1992). Intrinsic activity determinations at the dopamine D2 guanine nucleotide binding protein coupled receptor. Utilisation of receptor state binding affinities. Mol. Pharmacol., 42, 432-438.
15. LEE, T.W.T., SOLE, M.J. & WELLS, J.W. (1986). Assessment of a ternary model for the binding of agonists to neurohumoral receptors. Biochemistry, 25, 7009-7020.
16. LEFKOWITZ, R.J., COTECCHIA, S., SAMAMA, P. & COSTA, T. (1993). Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci., 14, 303-307.
17. MALMBERG, A., JACKSON, D.M., ERIKSSON, A. & MOHELL, N. (1993). Unique binding characteristics of antipsychotic agents interacting with human D2A, D2B and D3 receptors. Mol. Pharmacol., 43, 749-754.
18. MONTMAYEUR, J.P., GUIRAMAND, J. & BORELLI, E. (1993). Preferential coupling between dopamine D2 receptors and G-proteins. Mol. Endocrinol., 7, 161-170.
19. MCDONALD, W.M., SIBLEY, D.R., KILPATRICK, B.F. & CARON, M.G. (1984). Dopaminergic inhibition of adenylate cyclase correlates with high affinity agonist binding to anterior pituitary D2 dopamine receptors. Mol. Cell. Endocrinol., 36, 201-209.
20. MELLER, E., PUZA, T., MILLER, J.C., FRIEDHOFF, A.J. & SCHWEITZER, J.W. (1991). Receptor reserve for D2 dopaminergic inhibition of prolactin release in vivo and in vitro. J. Pharmacol. Exp. Ther., 257, 668-675.
21. NEUBIG, R.R., GANTZOS, R.D. & THOMSEN, W.J. (1988). Mechanisms of agonist and antagonist binding to α2 adrenergic receptors: evidence for a precoupled receptor-guanine nucleotide protein complex. Biochemistry, 27, 2374-2384.
22. NEVE, K. & NEVE, R.A. (1997). The Dopamine Receptors. Totowa, New Jersey: Humana Press.
23. NG, G.Y.K., O'DOWD, B.F., LEE, S.P., CHUNG, H.T., BRANN, M.R., SEEMAN, P. & GEORGE, S.R. (1996). Dopamine D2 receptor dimers and receptor blocking peptides. Biochem. Biophys. Res. Commun., 227, 200-204.
24. O'BOYLE, K.M. & LAWLOR, M. (1996). D2 receptor agonists and partial agonists: relationship between receptor binding measures and functional activity. Biochem. Soc. Trans., 24, 183-188.
25. 2-adrenergic receptor. J. Biol. Chem., 268, 4625-4636.
26. SENOGLES, S.E. (1994). The D2 dopamine receptor isoforms signal through distinct Giα proteins to inhibit adenylyl cyclase. A study with site directed mutant Giα proteins. J. Biol. Chem., 269, 23120-23127.
27. SIBLEY, D.R. & CREESE, I. (1983). Interaction of ergot alkaloids with anterior pituitary D2 dopamine receptors. Mol. Pharmacol., 23, 585-593.
28. SIBLEY, D.R. & MONSMA, F.J. (1992). Molecular biology of dopamine receptors. Trends Pharmacol. Sci., 15, 264-270.
29. 3H histamine in guinea pig cerebral cortex; mechanistic basis for multiple states of affinity. Mol. Pharmacol., 43, 583-594.
30. 3H]lisuride labels free receptor and receptor coupled to G-protein. J. Neurochem., 65, 1909-1916.
31. VALLAR, L. & MELDOLESI, J. (1989). Mechanisms of signal transduction at the D2 dopamine receptor. Trends Pharmacol. Sci., 10, 74-77.
32. VAN KOPPEN, C.J., SELL, H., LENZ, W. & JAKOBS, K.H. (1994). Deletion analysis of the m4 muscarinic receptor. Molecular determinants for activation of but not coupling to guanine nucleotide binding regulator protein regulate receptor internalisation. Eur. J. Biochem., 222, 525-531.
33. WREGGETT, K.A., (1987). Alkylation of the bovine anterior pituitary D2 dopamine receptor: inconsistency with the predictions of the ternary complex model. Biochem. Biophys. Res. Cummun., 147, 1070-1076.
34. WREGGETT, K.A. & DE LEAN, A. (1984). The ternary complex model: Its properties and applications to ligand interactions with the D2 dopamine receptor of the anterior pituitary gland. Mol. Pharmacol., 26, 214-227.
35. WREGGETT, K.A. & WELLS, J.A. (1995). Cooperativity manifest in the binding properties of purified cardiac muscarinic receptors. J. Biol. Chem., 270, 22488-22499.